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Abstract
Ozone is a commonly encountered environmental oxidant which has been linked to asthma 
exacerbation in epidemiological studies. Ozone induces airway inflammation and enhances 
response to inhaled allergen. It has been suggested that antioxidant therapy may minimize the 
adverse effects of ozone in asthma. We have previously shown that the antioxidant gamma-
tocopherol (γT), an isoform of vitamin E, also has anti-inflammatory effects. We employed a 
Brown Norway rat model of ozone-enhanced allergic responses to test the therapeutic effects of 
γT on O3-induced airway inflammation. Ovalbumin (OVA) -sensitized rats were intranasally 
challenged with 0 or 0.5% OVA on Days 1 and 2, and exposed to 0 or 1 ppm ozone (8h/day) on 
Days 4 and 5. Rats were also given 0 or 100 mg/kg γT on Days 2 through 5. Pulmonary tissue and 
bronchoalveolar lavage fluid (BALF) were collected on Day 6. OVA challenge caused increased 
total cells (267% increase) and eosinophils (4000%) in BALF that was unaffected by ozone 
exposure. Morphometric evaluation of lung tissue revealed increases in intraepithelial 
mucosubstances (IM) (300%) and subepithelial eosinophils (400%) in main axial airways. Ozone 
exposure of allergic rats enhanced IM increases in proximal axial airways (200%), induced cys-
leukotrienes, MCP-1 and IL-6 production in BALF, and upregulated expression of IL-5 and IL-13 
mRNA. γT treatment had no effect on IM increases by allergen, but blocked enhancement by 
ozone. γT attenuated both OVA- or ozone –stimulated eosinophilic infiltration, and increases of 
BALF cys-leukotrienes, MCP-1 and IL-6, as well as IL-5 and IL-13 mRNA. These data 
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demonstrate broad anti-inflammatory effects of a γT and suggest it may be an effective therapy of 
allergic airway inflammation.
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INTRODUCTION
Epidemiological studies implicate a role for ozone, the most prominent oxidant pollutant in 
photochemical smog, in the exacerbation of allergic airway diseases. Increases in ambient 
ozone concentration are associated with hospital admissions and reported symptoms from 
individuals with asthma and allergic rhinitis [1-3]. In challenge studies of asthmatic subjects, 
our research group has shown ozone induces eosinophilic infiltration in both upper and 
lower airways, decrements in pulmonary function, and enhances response to allergen [4-6]. 
Even in the absence of provocation with an allergen, atopic asthmatics appear to mount 
greater airway inflammatory responses after ozone exposure than healthy subjects [7, 8].
Specific mechanisms by which ozone exacerbates allergic responses are incompletely 
understood. Asthma is a disease of chronic inflammation in which an imbalance of oxidant 
versus antioxidant species is thought to contribute to disease severity and incidence of 
symptoms. Decreases in antioxidant vitamins E and C, and increases in oxidized glutathione 
have been reported in airway fluids of asthmatics [9-11]. In addition, enzymatic anti-
inflammatory capacity in the lung and plasma of asthmatics is depressed as indicated by 
lower activities of glutathione peroxidase, superoxide dismutase and catalase [12-14]. 
Deficient defenses in the airway microenvironment could allow for increased sensitivity to 
further oxidative insult by ozone exposure. Deficits in the antioxidant repertoire in allergic 
airways may be due to a lower dietary intake of antioxidants compounds such as from fruits 
and vegetables, especially in persons with genetically defined decreases in antioxidant 
defense. In case studies, intake of vitamins C, E and carotene by asthmatics was inversely 
correlated with symptom severity [15-17], and asthmatics tend to have lower amounts of 
antioxidant nutrients in their diets, especially of vitamins E and C [18].
Although α-tocopherol (αT), the major form of vitamin E in mammalian tissues is thought 
to neutralize lipid radicals, and inhibit cyclooxygenase (COX) and leukotriene synthesis 
[19], intervention with αT supplements failed to appreciably improve allergic airway 
symptoms in both human and animal studies [20-22]. However, γ-tocopherol (γT), the major 
form of vitamin E in US diets, has been demonstrated to be more powerful in trapping 
electrophiles such as reactive nitrogen species [23, 24] and displays a broader anti-
inflammatory profile than αT [25]. In addition to neutralizing oxidized lipid radicals, γT also 
protects both lipids and proteins from nitrosative damage from nitric oxide-derived 
metabolites [26, 27] and is a more potent inhibitor of COX activity than αT [28]. 
Furthermore, in an animal model of inflammation, we have shown that γT is superior to αT 
for inhibition of key mediators of inflammation such as TNFα, nitric oxide, and 
inflammatory eicosanoid production [29].
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We hypothesized that the γT form of vitamin E would inhibit pollutant and allergen induced 
exacerbation of allergic airway inflammation. To test this hypothesis, we used a rodent 
model of allergic airways disease to assess the ability of γT to prevent ozone and allergen-
induced exacerbation of airway inflammation. As described herein, we observed that γT 
attenuated allergen-and ozone-induced inflammatory cell recruitment, cytokine gene 
expression, and overproduction of mucus that characterizes asthma.
MATERIALS AND METHODS
Animals
Fifty-six male Brown Norway rats (Harlan, Indianapolis, IN), 10-12 weeks of age, were 
randomly assigned to one of 8 experimental groups (n = 7/group). Rats were free of 
pathogens and respiratory disease, and used in accordance with guidelines set forth by the 
All-University Committee on Animal Use and Care at Michigan State University. Animals 
were housed two per cage in polycarbonate boxes on aspen chip bedding, covered with filter 
lids, and had free access to tap water and food (Tek Lad 22/5 Rodent Diet W 8649, Harlan 
Sprague Dawley, Indianapolis, IN). During the inhalation portion of the study, rats were 
housed individually in rack-mounted stainless steel wire cages in Hazelton whole-body 
inhalation exposure chambers (HC-100, Lab Products, Maywood, NJ). During ozone 
exposure, food was removed, but water was available.
γ-Tocopherol
γ-gamma-tocopherol (γT; R,R,R naturally occurring, 96% pure by HPLC and NMR) was 
obtained from Yasoo Health Inc (Johnson City, TN). Stock and diluted preparations were 
kept under nitrogen at 4°C and contained no other tocopherols/tocotrienols or oxidation 
products. Prior to treatment protocols γT was diluted in tocopherol-stripped corn oil (Dyets 
Inc., Bethlehem, PA).
Ozone Exposure
Ozone was generated with an OREC model O3V1-O ozonizer (Ozone Research and 
Equipment Corp., Phoenix, AZ) using compressed air as a source of oxygen. Total airflow 
through the exposure chambers was 250 L/min (15 chamber air changes/h). The 
concentration of ozone within the chambers was monitored throughout the exposure using 
two Dasibi 1003 AH ambient air ozone monitors (Dasibi Environmental Corp., Glendale, 
CA). Sampling probes were placed in the breathing zone of rats within the middle of the 
cage racks. The concentration of ozone during exposures was 0.994 ±0.012 ppm (mean ± 
SEM) for ozone chambers and less than 0.02 ppm for chambers receiving filtered air. Ozone 
concentrations of 1ppm were used to enhance allergic responses in a rat strain that is 
comparatively less sensitive to ozone than other rats or humans. Pulmonary ozone dosimetry 
studies demonstrate that humans have 4-5 times greater pulmonary deposition of inhaled 
ozone than Fisher F344 rats [30], and that rats required greater exposures for similar 
responses. Furthermore the Brown Norway rat is much less sensitive to ozone than F344 
rats. As such, 1 ppm ozone in Brown Norway rats provides a reasonable exposure scenario 
to what might occur in humans.
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Treatment and Exposure Protocols
The time course for treatment protocols is summarized in Figure 1. On Day 1, rats were 
sensitized to chicken albumin (ovalbumin; OVA; Sigma Chemical Co., St. Louis, MO) by 
intraperitoneal injection with 2.5 ml sterile saline of a solution containing 1 mg OVA 
prepared with 10 mg alum (aluminum potassium sulfate) which acts as an adjuvant. Two 
weeks later rats were challenged to OVA or saline for two consecutive days (i.e., Days 14 
and 15) under light anesthesia (4% halothane in oxygen) by intranasal instillation (IN) with 
150 μl of 0 or 0.5% OVA in saline into each nasal passage (300 μl total volume). IN 
challenge procedures were conducted at 10:00am each day.
Beginning 8h after the last IN challenge, rats were administered by oral gavage, 100 mg/kg 
body weight γT prepared in tocopherol-stripped corn oil. Treatment with γT was repeated 
daily at 6:00pm for four consecutive days (Days 15-18). Beginning on Day 17, animals were 
exposed to 0 or 1.0 ppm ozone for 8h/day (7:30am – 3:30pm) for two consecutive days 
(Days 17 and 18). Animals were euthanized and tissues were collected on Day 19.
Necropsy, Lavage Collection and Tissue Preparation
Animals were anesthetized with sodium pentobarbital (50 mg/kg), a midline laparotomy was 
performed, 4 ml of blood was drawn into a vacutainer for separation of plasma, and animals 
were exsanguinated by cutting the abdominal aorta. Immediately after death, the trachea was 
exposed and cannulated, the heart and lung were excised en bloc. The bronchus to the left 
lung was temporarily closed with a hemostatic clamp, and 4 ml of sterile saline was instilled 
through the tracheal cannula and withdrawn to recover bronchoalveolar lavage fluid (BALF) 
from the right lung lobes. A second saline lavage was performed and combined with the 
first.
After lavage, the right lung lobes were ligated and removed. The axial conducting airway 
from the right caudal lobe was removed by microdissection and homogenized in 0.5 ml 
RNAlater (Qiagen Inc., Valencia, CA) using a post-mounted homogenizer with a 5-mm 
generator (Model 250, Pro-Scientific, Inc., Monroe, CT). The right cranial lobe was also 
excised and placed in RNAlater. Samples were kept at –80°C until further processing for 
RNA isolation. The clamp was removed from the left bronchus, and the left lobe was 
inflated under constant pressure (30 cm H2O) with neutral-buffered formalin for 2h, while 
immersed in a large volume of fixative. Twenty-four hours later, two sections were excised 
at the level of the 5th and 11th airway generation along the main axial airway (G5 and G11), 
to sample proximal and distal airways, respectively (Harkema and Hotchkiss, 1992).
Tissue blocks were then embedded in paraffin, and 5-6 μm thick sections were cut from the 
anterior surface. Lung sections were stained with hematoxylin and eosin (H&E) for routine 
histology, with Alcian Blue (pH 2.5)/Periodic Acid-Schiff (AB/PAS) to detect intraepithelial 
mucosubstances, or with May Grunwald stain to detect eosinophils.
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Bronchoalveolar Lavage Fluid (BALF)
Cellularity—Total leukocytes in BALF were enumerated with a hemocytometer, and 
fractions of eosinophils, neutrophils, macrophages, and lymphocytes were determined in a 
cytospin sample stained with Diff-Quick (Dade Behring, Newark, DE).
Cytokine and Leukotriene Content—For leukotriene analysis, cell-free BAL fluid was 
first purified in 2mL methanol and 5mL hexane to precipitate proteins and lipid, 
respectively. The methanol layer containing leukotrienes was dried under N2 stream. The 
amount of LTB4 and total cysteinyl-leukotrienes (LTC4, LTD4 and LTE4) were measured 
using an EIA assay from Cayman Chemicals (Ann Arbor, MI). Cytokine content in BAL 
fluid was determined using a custom bead-based multiplex assay capable of detecting 15 
different rat protein targets. Assays are conducted in 96-well MultiScreen plates (Millipore) 
by the same principle of standard ELISA. Bound protein:antibody conjugates on beads are 
detected using a Streptavidin-PE system and analyzed using the Luminex100 total system 
(Luminex Corp, Austin, TX).
Tocopherols—Plasma and BAL fluid αT and γT were extracted using a mixture of 
methanol/hexane (2:5, v/v) in the presence of 0.8 mM butylated hydroxytoluene (BHT). 
After brief centrifugation at 4°C, the top hexane layer was dried under N2 and the residue 
was resuspended in ethanol. Tocopherols were separated on a 150 × 4.6 mm, 5 μm 
Supelcosil™ LC-18-DB column (Supelco, Bellefonte, PA, USA) and eluted with 95:5 (v/v) 
methanol/0.1M lithium acetate (final 25 mM, pH 4.75) at a flow rate of 1.3 mL/min. 
Tocopherols were monitored by coulometric detection (Model Coulochem II, ESA Inc., 
Chelmsford, MA, USA) at 300 (upstream) and 500 mV (downstream electrode) using a 
Model 5011 analytical cell.
Real Time RT-PCR
Total RNA was extracted using Rneasy Mini Kit according to manufacturers instructions 
(Qiagen, Valencia, CA). The evaluation of relative expression levels of IL-5 and –13 mRNA 
was performed by two-step RT-PCR using manufacturer protocols (Applied Biosystems, 
Foster City, CA). Briefly, reverse transcription was performed using High Capacity cDNA 
archive Kit reagents. Quantitative mRNA expression analysis was performed using an ABI 
PRISM 7900 HT Sequence Detection System at Michigan State University's Research 
Technology Support Facility using Taqman Gene Expression Assay reagents (Applied 
Biosystems). Relative gene expression was normalized to 18S. Data is expressed as fold-
increase in RNA expression compared to control animals, which are set at a value of 1.
Morphometry of Stored Intraepithelial Mucosubstances (IM)
To estimate the amount of the intraepithelial mucosubstances (IM) in respiratory epithelium 
lining pulmonary axial airways, the volume density (Vs) of AB/PAS-stained 
mucosubstances was quantified using computerized image analysis and standard 
morphometric techniques. The area of AB/PAS stained mucosubstance was calculated from 
the automatically circumscribed perimeter of stained material using the public domain NIH 
Image program (written by Wayne Rasband, U.S. National Institutes of Health and available 
on the Internet at http://rsb.info.nih.gov/nih-image/). The length of the basal lamina 
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underlying the surface epithelium was calculated from the contour length of the digitized 
image of the basal lamina. The volume density (Vs) of intraepithelial mucosubstances is 
expressed as nanoliters of intraepithelial mucosubstances per mm2 of basal lamina.
Morphometry of Tissue Eosinophil Numeric Density
The numeric density of eosinophils in the mucosa underlying the respiratory epithelium of 
conducting pulmonary airways, were determined by counting May-Grunwald-positive 
stained cells with distinct eosinophil morphology. The length of the basal lamina was 
calculated from its contour length in a digitized image as described above, and the data is 
expressed as the number of eosinophils divided by the length of the underlying basal lamina.
Statistical Analysis
Data are expressed as mean ± standard error of the mean (SEM). Data were analyzed using a 
completely randomized analysis of variance. Multiple comparisons were made by Student-
Newman-Keuls post hoc test. Criterion for significance was taken to be p ≤ 0.05.
RESULTS
Tocopherol Content in Plasma and BALF
γT was not detected in BALF from corn oil vehicle treated rats regardless of ozone exposure 
or allergen challenge (Figure 2A). Administration with γT produced measurable levels of 
this tocopherol in all BALF samples, but there were no differences in any treatment group 
compared to saline/air controls. αT was detected in all BALF samples (Figure 2B). 
Treatment related changes were detected only in ozone-exposed allergic rats given 0 mg/kg 
γT (Figure 2B), while apparent increases in similarly ozone-treated rats given 100 mg/kg γT 
were not statistically significant (p=0.053).
Plasma γT was unaffected by any exposure or challenge regimens in control, corn oil-fed 
rats, but was increased in all groups 4 to 5-fold by administration with 100 mg/kg γT. No 
differences were detected between exposure or challenge groups (Figure 2C). Plasma αT 
was similar in all groups given 0mg/kg γT, with trends toward decreases in OVA-challenged 
rats (Figure 2D). Allergic animals dosed with 100mg/kg γT and exposed to filtered air had 
significantly less αT in plasma than saline-challenged, air-exposed rats.
Histopathology
Rats instilled with saline and exposed to ozone—No exposure related lesions were 
found in the lungs of filtered air-exposed rats that were intranasally instilled with only 
saline. In contrast, repeated ozone exposures induced site-specific lung lesions that were 
restricted to centriacinar regions (junction of terminal bronchioles and proximal alveolar 
ducts) throughout the lung lobe (Figure 3E). These centriacinar lesions were characterized 
by a conspicuous thickening of the walls of terminal bronchioles and proximal alveolar 
ducts with associated small aggregates of alveolar macrophages/monocytes and lesser 
numbers of neutrophils, eosinophils and lymphocytes in the alveolar airspaces of the 
proximal alveolar ducts. Intramural thickening was mainly due to 1) a mild-moderate influx 
of mixed inflammatory cells consisting of neutrophils, eosinophils, and mononuclear 
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inflammatory cells (lymphocytes and monocytes) and 2) an associated hypertrophy and 
hyperplasia of cuboidal epithelial cells lining the centriacinar airways (Figure 3E). Mucous 
cell hyperplasia/metaplasia, a principal feature in the conducting airway epithelium of 
ovalbumin-instilled rats, was not present in the large- and small-diameter conducting 
airways of these saline-instilled and ozone-exposed rats. The alveolar parenchyma outside of 
the centriacinar regions resembled that of the control rats instilled with saline and exposed 
only to filtered air (0 ppm ozone). Interestingly, treatment with γT did not alter the 
morphologic character or severity of the centriacinar lesions caused by the ozone exposures 
(Figure 3F).
Rats instilled with ovalbumin (OVA) and exposed to air alone or ozone—
Intranasal challenge of OVA in filtered air or ozone-exposed rats induced an allergic 
bronchiolitis of the intrapulmonary conducting airways involving both large-diameter, 
proximal, axial airways and small diameter, distal, preterminal and terminal bronchioles. 
The OVA-induced inflammatory and epithelial changes in the conducting airways within the 
proximal transverse section of the left lung lobe (axial airway level G5) were more marked 
than those in the distal lung lobe section (axial airway level G11), indicating a proximal-
distal decrease in the lobar lesion severity and distribution. OVA-induced bronchiolitis was 
characterized by peribronchiolar edema associated with a mixed inflammatory cell influx of 
lymphocytes, plasma cells, eosinophils, and occasional neutrophils (Figure 3C). 
Peribronchiolar inflammation was principally located in the subepithelial interstitial tissues 
(e.g., lamina propria and submucosa) with markedly fewer inflammatory cells in the surface 
epithelium that lines these airways. Bronchiole-associated lymphoid tissues in these OVA-
challenged airways were also enlarged due to lymphoid hyperplasia. Perivascular interstitial 
(i.e., surrounding pulmonary arteries/arterioles adjacent to bronchioles and pulmonary veins 
scattered throughout the alveolar parenchyma) accumulation of a similar mixture of 
eosinophils and mononuclear cells, along with perivascular edema, were also present in the 
lungs of OVA-challenged rats (Figure 3E).
In addition to the perivascular and peribronchiolar lesions, there were varying sized focal 
areas of allergic alveolitis in the parenchyma surrounding or adjacent to the affected large 
and small conducting airways. These alveolar lesions were characterized by accumulations 
of large numbers of alveolar macrophages, epithelioid cells, and eosinophils, with lesser 
numbers of lymphocytes, monocytes and plasma cells, in the alveolar airspace. Often the 
alveolar septa in these areas of alveolitis were thickened due to mild-to-moderate alveolar 
type II cell hyperplasia/hypertrophy, intracapillary accumulation of inflammatory cells, and 
capillary congestion.
OVA-challenged rats exposed to either filtered air or ozone had conspicuous hypertrophy 
(tall columnar epithelial cells) and mucous cell metaplasia/hyperplasia (MCM) with 
increased amounts of AB/PAS-stained intraepithelial mucosubstances (IM) in the respiratory 
epithelium lining the large-diameter intrapulmonary airways, including the proximal axial 
airway (G5) and to a much lesser extent in the distal axial airway (G11) and the small-
diameter preterminal and terminal bronchioles (Figure 4B, E). In contrast, saline-instilled 
rats exposed to either filtered air (Figure 4A, D) or ozone had significantly fewer mucous 
cells and IM in a much thinner, low columnar, respiratory epithelium lining large-diameter 
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airways. Very few or no mucous cells with only scant amounts of IM were present in the 
respiratory epithelium lining small diameter preterminal bronchioles of these saline-instilled 
animals. Terminal bronchioles of saline-instilled rats contained no mucous cells. 
Interestingly, epithelial and inflammatory lesions observed in the centriacini of ozone-
exposed rats intranasally instilled with only saline, described above, were not 
microscopically detectable in the ozone-exposed, OVA-challenged rats, even in those 
centriacinar regions with little or no OVA-induced lesions (Figure 3G).
Treatment with γT markedly attenuated OVA-induced epithelial and inflammatory lesions in 
both the intrapulmonary proximal and distal conducting airways and in the alveolar 
parenchyma (Figure 3D). Airway epithelial thickening with MCM, peribronchial and 
perivascular inflammatory cell influx, and alveolitis were all markedly reduced both in 
severity and distribution in the lungs of OVA-challenged rats that were exposed either to 
filtered air alone or ozone (Figures 3,4). Surprisingly, centriacinar inflammatory and 
epithelial lesions similar to those observed in the saline-instilled rats exposed to ozone were 
also present in the OVA-challenged, ozone-exposed rats that received γT, indicating that γT 
treatment was effective in attenuating allergen- but not oxidant-induced pulmonary injury in 
Brown Norway rats (Figure 3H).
Bronchoalveolar Lavage Fluid (BALF)
Cellularity—Ozone exposure of saline-challenged rats had no effect on lavage cellularity 
(Figure 5). Conversely, provocation of allergic rats with OVA induced significant 
accumulation of total cells, eosinophils, and macrophages in BALF, that was unaffected by 
ozone exposure. However ozone exposure of OVA-challenged animals caused increases in 
BALF neutrophils compared to OVA-challenged rats exposed to filtered air (Figure 5). γT 
supplementation led to a reduction of OVA- and ozone-induced increases in BALF total 
cells, eosinophils, and macrophages, but not neutrophils. Furthermore, neutrophils were 
significantly greater in saline-challenged, ozone-exposed animals given γT compared those 
dosed with corn oil.
Leukotrienes and Cytokines—Ozone exposure or OVA challenge alone had no effect 
on cysteinyl leukotrienes (Cys-LTs) levels in BALF (Figure 6A). However ozone exposure 
to allergic rats increased Cys-LTs by 3-4 fold over controls, which was blocked completely 
by γT supplementation. Increases in BALF LTB4 in allergic rats were not statistically 
significant, irrespective of ozone exposure (Figure 6B). γT caused a reduction of LTB4 in 
allergic rats exposed to ozone, compared to similarly treated rats given corn oil.
BALF MCP-1 was unaffected by ozone exposure alone but was increased 4-fold in OVA-
challenged rats (Figure 6C). Ozone exposure further enhanced MCP-1in allergic rats by 
another 3-fold. Only allergic rats exposed to ozone had significant amounts of IL-6 in 
BALF. Both ozone-induced responses in BALF MCP-1 and IL-6 were attenuated by 
supplementation with γT.
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Mucous Cell Metaplasia and Eosinophilic Inflammation—Two consecutive days of 
ozone exposure did not alter the amount of IM in pulmonary airways (Figure 7A & B). 
Challenge with OVA caused mucous cell metaplasia (i.e., increased IM) in the respiratory 
epithelium lining distal pulmonary axial airways (Figure 7B), while apparent increases in IM 
in proximal airways were not statistically significant (Figure 7A). However, ozone exposure 
caused IM levels to be significant in proximal airways of allergic rats, with a trend toward 
further increases in distal airways (p=0.21). Treatment with γT attenuated the increases in 
IM in both proximal and distal airways of ozone-exposed allergic rats. By contrast, OVA-
induced increases in IM remained elevated in γT-treated, OVA-challenged rats exposed to 
filtered air.
OVA challenge induced a 4- to 5-fold increase in the number of eosinophils in the 
submuscosa surrounding proximal and distal axial airways (Figures 7C & D). Ozone 
exposures induced a non-significant trend for increased eosinophil accumulation in allergic 
rats. In both air- and ozone-exposed allergic rats given γT, eosinophil numbers were 
attenuated in both proximal and distal airways.
Gene Expression
Allergic rats exposed to ozone were characterized by higher expression levels of 
inflammatory genes IL-5 (1.9-fold) and IL-13 (2.9-fold) in the cranial lung lobe (Figure 8). 
Changes induced by allergen alone were not statistically different from those detected in 
control animals. Supplementation with γT inhibited ozone-induced changes in gene 
expression for both IL-5 and IL-13.
DISCUSSION
This study was designed to determine if γT inhibited ozone-induced exacerbation of allergic 
inflammation in a rodent model of allergic inflammation. Our models using the allergic 
Brown Norway rat mimics the human clinical condition in which asthma exacerbations are 
induced by ozone exposure. In the present protocol, we generally found that ozone alone had 
little effect on airway inflammation of OVA-sensitized rats, but challenge with OVA alone 
or OVA plus ozone had remarkable effects on many elements of allergen-induced 
inflammation. Intriguingly, ozone did not appear to augment cellular responses to OVA 
(eosinophil influx), but dual exposure to both agents was necessary to induce increases in 
inflammatory mediators, gene expression and mucous cell metaplasia.
We found that short-term acute supplementation with γT inhibited inflammatory changes in 
airways of OVA-sensitized rats, whether they were challenged with OVA alone, or with 
OVA coupled with ozone exposure. Dosing with γT attenuated inflammatory cell 
recruitment, airway cytokine and leukotriene production, epithelial cell metaplasia, mucous 
storage, and gene expression. It is noteworthy that the anti-inflammatory effects of γT were 
observed with acute dosing that occurred after acute challenges with allergen. Thus, it was 
not necessary to supply γT for several days prior to challenge, suggesting that rapidly 
induced serum changes in γT, rather than chronic changes in tissue levels of γT or its 
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metabolites were sufficient to protect against inflammatory changes due to ovalbumin or 
ozone. These novel effects suggest that γT might be an affective adjunct or complementary 
intervention for asthma.
We used pharmacological doses of 100mg/kg γT in rodents, which extrapolates to about 6-
times the human recommended upper limit for the alpha-form of Vitamin E. However 
preliminary data in our laboratory suggests that antiallergic effects of γT may occur as low 
as 10mg/kg (data not shown). Although the doses appropriate to humans need to be 
established, the bioavailability of γT in human tissues are much higher than that in rodents; 
concentrations of γT in human skin, adipose and muscle tissue are 6-60 fold greater than 
those in laboratory rodents with similar γT intake [31, 32].
We designed our protocols for γT pretreatment to specifically target airway responses to 
ozone exposure by dosing with γT after initiating allergic inflammation, but before 
beginning exposures to ozone. One of our striking findings however, is that γT specifically 
inhibited allergen-induced responses, despite being administered 10 hours after the second 
of two airway provocations with allergen. OVA-induced increases in BALF eosinophils and 
macrophages (Figure 5), MCP-1 (Figure 6), and eosinophilic inflammation surrounding 
conducting airways (Figure 7), were all attenuated by γT supplementation in air-exposed 
animals. Furthermore the extent and severity of pulmonary lesions in allergic lungs, 
including interstitial edema and the involvement of both bronchiolar and alveolar airways, 
were markedly decreased in rats given γT. These data demonstrate that acute dosing with γT 
can arrest ongoing pulmonary inflammation that is downstream from the initial allergic 
stimulus and does not require weeks of dietary intake to produce therapeutic effects. By 
contrast, the present protocols did not test if γT could prevent responses from the initial 
interactions of airway allergen, such as uptake by dendritic cells or IgE-mediated activation 
of alveolar macrophages and mast cells. The possible prophylactic effects of γT on allergic 
responses are currently under investigation.
In addition to blocking responses engendered by OVA provocation, γT also attenuated all 
ozone-induced enhancements of allergic responses. Under the current experimental design, 
γT was administered twice by the time of the first ozone exposure, and administered 
immediately after each exposure (Figure 1). This acute supplementation regimen was 
apparently sufficient for pulmonary γT to block any acute oxidant or inflammatory stimuli 
induced by inhalation with ozone. We have previously described the requirement for 
neutrophils in the initiation and progression of ozone-induced MCM in a non-allergic model 
[33], as well as associations of eosinophils and neutrophils with MCM in allergic models 
[34]. In the present study, eosinophilic infiltrates that were dramatically increased in BALF 
by allergen were attenuated by supplementation with γT. We also saw a trend for ozone-
induced enhancement of tissue eosinophils that was inhibited by γT. Although ozone did not 
dramatically enhance eosinophil numbers in allergic rats, ozone (or mediators generated 
after ozone exposure) may activate inflammatory cells that infiltrate tissues after allergen 
challenge to release factors that promote MCM. This idea is supported by our observation 
that ozone exposure coupled with OVA challenge (but neither stimulus alone) led to a 
significant increase in cysteinyl leukotrienes (cysLTs), MCP-1, and IL-6 as indicated by 
their increases in BALF (Figure 6). These mediators were not present in allergic animals 
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exposed to filtered air, despite significant infiltration of inflammatory cells into lung tissue. 
Ozone promotes lipoxygenase activity in the lung [35], and cysLTs have been shown to 
induce MCM in allergic rodents [36, 37]. Eosinophils and IgE-activated mast cells are 
primary sources of cysLTs in allergic airways. That ozone can activate both mast cells [38] 
and eosinophils [39] in healthy airways, suggests it may promote allergic MCM by 
stimulating eosinophils, mast cells and other inflammatory or epithelial cells for enhanced 
production of inflammagens, including cysLTs. Complete blockade by γT of BALF cysLTs 
agrees with our previous finding of LOX inhibition by γT [29]. Taken together, the 
therapeutic effects of γT in ozone-exposed allergic rats may be due to inhibitions of OVA-
initiated inflammatory cell recruitment and ozone-induced activation of inflammatory and 
epithelial airway cells.
Interestingly, γT was effective at resolving the ongoing responses of inflammatory cell 
infiltration (Figure 5), but had no effect on allergic mucous cell metaplasia (Figure 7). These 
differential inhibitory effects might be explained by the acute versus chronic stimuli elicited 
by 1) acute allergen exposure, and then 2) the cascade of cellular and soluble mediators 
engendered over a period of hours and days. Recurring signals for cell recruitment and 
activation persist well after the initial allergen stimulus, and are still present when γT dosing 
begins. In contrast, metaplastic changes to airway epithelium (e.g., mucous cell metaplasia) 
are a relatively long-lived phenotypic alteration that is initiated by signaling pathways 
present early after an allergen challenge (e.g., 6-48h). These early pathways of mucin gene 
expression and metaplasia have been shown to involve intracellular reactive oxygen species 
[40, 41], production of which during our protocol would likely occur well before 
supplementation with by γT. Thus, interruption by γT of allergic inflammation versus its 
lack of effect on allergic mucous cell metaplasia may be dependent on the timing of γT 
supplementation during allergic processes.
There may be multiple mechanisms that account for inhibition of elements of both allergen- 
and ozone-induced inflammation by γT, especially given that ozone and allergen-induced 
inflammation likely involve different mechanisms. Ozone is an oxidant gas, which induces 
epithelial cell injury and production of ozonated lipid mediators, followed by secondary 
responses of inflammatory cell recruitment. By comparison, allergic inflammation involves 
activation of mast cells, lymphocytes, epithelial cells and eosinophils. These multiple cell 
types are sources of various mediators, including eosinophil-derived granular proteins, 
peroxidases, leukotrienes and interleukins, and mast cell-derived tryptase, histamine and 
leukotrienes.
Using γT in models of non-allergic inflammation, we have previously described its ability to 
inhibit lipoxygenase (LOX) and cyclooxygenase (COX) activities [28, 29]. In the present 
study we present similar findings of decreased cysLT and a trend for lesser amounts of 
LTB4 in BAL fluid. Well known as a neutrophil chemoattractant, a critical role for LTB4 
has recently been described for the recruitment and activation of IL-13-producing T cells 
[42]. Both IL-13 and cysLTs promote allergic inflammatory responses, including mucin 
gene expression [36, 43]. These data suggest that the anti-eicosanoid actions of γT likely 
account for a significant fraction of the anti-allergic effects we observed in this study.
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There are other potential mechanisms by which γT may minimize inflammatory responses in 
the airway. One potential common inflammatory mechanism that may play a role in both 
ozone and allergen-induced inflammation is, production of reactive oxygen species (ROS) 
and formation of lipid peroxides, as these can be induced by either ozone or allergic stimuli. 
These oxidant mediators are likely targets for the antioxidant activities of tocopherols such 
as γT and αT, both which can directly neutralize superoxide anion, singlet oxygen and lipid 
peroxyl radicals, though γT is relatively less potent for quenching most ROS than is αT [27].
However, reactive nitrogen species, such as nitric oxide and peroxynitrite, which lead to the 
nitration of cellular lipids, proteins and nucleotides also cause significant inflammatory 
changes and injury in tissues during allergy. The protective effects of γT may be mediated 
by the neutralization of reactive nitrogen species, such as nitric oxide and peroxynitrite, 
which lead to the nitration of cellular lipids, proteins and nucleotides. Supporting this idea is 
the observations that γT (but not αT) is a highly efficient quencher of nitric oxide and 
peroxynitrite in vitro [26], and that γT can inhibit protein nitration during systemic 
inflammation in laboratory rodents [44]. This may be very relevant to allergen-induced 
inflammation, as nitric oxide production during allergic inflammation, primarily from 
eosinophils, has been implicated in the nitration and inactivation of key anti-inflammatory 
and protective enzymes, including catalase, superoxide dismutase, and glutathione 
transferases [14]. It is reasonable therefore to speculate that γT could provide protection 
from nitrosative stress that occurs in allergic airways with eosinophilia. Though we did not 
assess markers of ROS or RNS in these studies, this is clearly an important focus for 
subsequent studies of the actions of γT in asthma.
It has also been reported that γT can upregulate peroxisome proliferator activated receptor – 
gamma (PPARγ), [45, 46] a nuclear transcription factor that regulates many inflammatory 
genes including those expressed in the asthmatic tissues. Specifically, PPARγ can modulate 
eosinophil survival and activation [47], as well as epithelial mucin production [48]. It is 
possible that the relatively rapid effects of γT against allergen-induced inflammation could 
be mediated by an acute activation of PPARγ to inhibit signaling cascades that lead to 
airway inflammatory cell recruitment and activation. This is another mechanistic focus for 
subsequent studies of the effect of γT on airway inflammation.
In clinical studies, most vitamin E intervention studies directed against ozone-induced 
respiratory disease have used αT, which is the predominant form of vitamin E in 
mammalian tissues and for which the recommended dietary allowance (RDA) has been 
established. Intervention with combination therapy with αT and vitamin C protected from 
pulmonary function deficits in asthmatic children with decreased intake of dietary 
antioxidants during high ambient ozone episodes in Mexico City [49], though this effect was 
most pronounced in children with genetic mutations for glutathione-S-transferase M1, a key 
enzymatic mediator that opposes pathways of oxidative stress [50]. In a separate study of 
healthy subjects with limited dietary ascorbate, supplementation with αT, vitamin C and 
vegetable juice protected them from ozone-induced decrement in pulmonary function but 
not from airway inflammation [51]. These two studies are in contrast to a recent report by 
Mudway and colleagues [52], who used supplements with twice the concentrations of αT 
and vitamin C used above, but failed to inhibit lung function decrements and airway 
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inflammation after acute 2h ozone exposures. Taken together, these studies suggest that αT 
is most effective in populations with a decreased intake of dietary antioxidants.
Compared to combination supplements, intervention with large doses of αT alone is much 
less effective against allergic airway responses. For example, daily supplements of 250mg 
αT (16 times the RDA of 15mg/d, for 6 weeks) provides no improvement in airway function 
or bronchodilator use in asthmatics [20]. Doses of 800mg αT /day (53 times RDA) in 
patients with allergic rhinitis fail to ameliorate symptom severity [22]. Similar results were 
recently reported in rodents with allergic airways where oral administration of 400 
mg/kg/day αT for 10 days failed to reduce allergen-induced pulmonary lesions or airway 
hyperreactivity [21]. Using a very similar allergen sensitization and challenge protocol, we 
observed inhibition of ozone and allergen-induced allergic inflammation with only 4 days of 
treating with a much smaller dose of γT. This comparison is reminiscent of our findings in a 
non-immunogenic inflammation in rats, where γT was superior to αT in limiting 
inflammatory cell recruitment and cytokine production [29]. The role of γT in ozone-induce 
airway responses has not been extensively examined in either laboratory animals or humans. 
However, acute ozone exposure to BALB/c mice preferentially increased γT, ascorbate and 
uric acid in BAL fluid compared to αT [53], which is similar to the trend we detect for 
BALF γT from ozone-exposed rats in the present study. These results in laboratory rodents 
suggest that the γ-isoform of vitamin E may play a relatively more important role in 
regulating pulmonary inflammation than αT
Taken together, we have demonstrated broad and novel anti-inflammatory effects of γT after 
exposure to OVA allergen and/or ozone, two disparate stimuli. We furthermore described 
therapeutic effects with a relatively acute dosing regimen, and suggest that γT does not 
require prophylactic use or repeated doses to produce efficacy. On the basis of these 
observations in laboratory animals, we are presently developing a rodent study to examine 
the effect of γT on airway inflammation induced only by allergen as well as a series of phase 
I studies to test the safety and efficacy of γT in allergic people coexposed to allergens and 
environmental pollutants.
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Figure 1. Experimental Protocol
Ovalbumin-sensitized Brown Norway rats were challenged with intranasal ovalbumin (Days 
14, 15) and then exposed to 0 or 1.0 ppm ozone (Days 17 & 18). Animals were given γT of 
vehicle beginning after challenge daily for the duration of the study (Days 15-18).
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Fig 2. Tissue tocopherol content
Normal and allergic Brown Norway rats were exposed to 0 or 1.0 ppm ozone and treated 
orally with 0 or 100 mg/kg γT as described previously. Plasma and bronchoalveoler lavage 
fluid was collected and analyzed for content of α- and γ-tocopherol by HPLC as described in 
Materials and Methods. Data are expressed as mean ± SEM. a = significantly different from 
respective group challenged with intranasal saline; b = significantly different from 
respective group exposed to 0 ppm ozone; c = significantly different from respective group 
treated with 0 mg/kg γT. Criteria for significance, p ≤ 0.05.
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Photomicrographs of the epithelium of conducting airways in lungs of rats challenged with 
saline (Sal) and treated with either corn oil (A) or γT (B); challenged with Ova and treated 
with corn oil (C) or γT (D); exposed to ozone (O3) and treated with corn oil (E) or γT (F); or 
challenged with Ova and exposed to ozone (Ova/O3), and then treated with corn oil (G) or 
γT (H). Tissues were stained with H&E. pa = pulmonary artery, tb = terminal bronchiole, ad 
= alveolar duct, ap = alveolar parenchyma.
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Photomicrographs of the respiratory airway epithelium lining the axial airway in lungs of 
rats (A,D) challenged with salineand treated corn oil respectively, (B,E) challenged with 
OVA, exposed to ozone and treated with corn oil, or (C,F) challenged with OVA, exposed to 
ozone and treated with γT. Tissues were stained with H&E (A,B,C) or AB/PAS (D,E,F) to 
identify intraepithelial mucosubstances (identified by arrows). e = epithelium; sm = smooth 
muscle; i = interstitium; arrowheads in H&E =inflammatory cells.
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Figure 5. Effect of γT on Inflammatory Cells Recovered in Bronchoalveolar Lavage Fluid
Normal and allergic Brown Norway rats were exposed to 0 or 1.0 ppm ozone and treated 
orally with 0 or 100 mg/kg γT as described previously. Bronchoalveoler lavage fluid was 
collected and cell enumerated as described in Materials and Methods. Data are expressed as 
mean ± SEM. a = significantly different from respective group challenged with intranasal 
saline; b = significantly different from respective group exposed to 0 ppm ozone; c = 
significantly different from respective group treated with 0 mg/kg γT. Criteria for 
significance, p ≤ 0.05.
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Figure 6. Soluble Inflammatory Mediators in BALF
Normal and allergic Brown Norway rats were exposed to 0 or 1.0 ppm ozone and treated 
orally with 0 or 100 mg/kg γT as described previously. Bronchoalveoler lavage fluid was 
collected and analyzed for cytokine and leukotrienes as described in Materials and Methods. 
Data are expressed as mean ± SEM. a = significantly different from respective group 
challenged with intranasal saline; b = significantly different from respective group exposed 
to 0 ppm ozone; c = significantly different from respective group treated with 0 mg/kg γT. 
Criteria for significance, p ≤ 0.05
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Figure 7. Effect of γT on Ozone-Induced Enhancement of Allergic Mucous Cell Metaplasia and 
Eosinophilic Inflammation in Pulmonary Axial Airways
Normal and allergic Brown Norway rats were exposed to 0 or 1.0 ppm ozone and treated 
orally with 0 or 100 mg/kg γT as described previously. Lungs sections from proximal (A) 
and distal (B) axial airways were stained with AB/PAS and intraepithelial mucosubstances 
were morphometrically analyzed as described in Materials and Methods. Lungs stained with 
May Grunwald were used to quantify eosinophils in proximal (C) and distal (D) axial 
airways. Data are expressed as mean ± SEM. a = significantly different from respective 
group challenged with intranasal saline; b = significantly different from respective group 
exposed to 0 ppm ozone; c = significantly different from respective group treated with 0 
mg/kg γT. Criteria for significance, p ≤ 0.05.
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Figure 8. Effect of γT on Inflammatory Gene Expression in Lung Tissue
Normal and allergic Brown Norway rats were exposed to 0 or 1.0 ppm ozone and treated 
orally with 0 or 100 mg/kg γT as described previously. RNA was isolated from the cranial 
lung lobe and analyzed by RT-PCR as described in Materials and Methods. Data are 
expressed as mean ± SEM. a = significantly different from respective group challenged with 
intranasal saline; b = significantly different from respective group exposed to 0 ppm ozone; 
c = significantly different from respective group treated with 0 mg/kg γT. Criteria for 
significance, p ≤ 0.05.
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